Merck

Merck & Co., Inc., known as MSD outside the U.S. and Canada, is a leading global biopharmaceutical company headquartered in the United States. Founded in 1891, Merck develops medicines, vaccines, biologic therapies, and animal health products. Its portfolio includes breakthrough drugs in oncology, vaccines, and infectious diseases. As of 2024, the company employs around 72,000 people worldwide. Merck is publicly traded on the New York Stock Exchange (NYSE: MRK) and reported annual revenues of over $59 billion. With operations in more than 140 countries, Merck is recognized for its commitment to research and development, investing billions annually in scientific innovation to improve patient outcomes. Merck delivers services and products across multiple industries, with a focus on innovation, customer needs, and regulatory compliance. The company engages in strategy development, technological advancement, and partnerships with a wide client base. Through investments in research, infrastructure, and employee development, Merck supports long-term growth. The company's portfolio spans solutions that address complex demands in an evolving global landscape. As part of its mission, Merck emphasizes sustainable practices, ethical governance, and resilience. In addition, Merck has implemented systems to manage risk, security, and operational efficiency.